Anyone with my email address is free to verify. I apologize to all for being off-line not standing in defense of what was clearly a bear raid based on ABSOLUTELY NOTHING!!! NOTHING HAS CHANGED and the so called downgrade makes NO SENSE (either way) because as almost all of us KNOW the outcome of Omontys and therefor Affymax is 100% BINARY!!! And I have not changed my convictions one iota that this "binary event" will break towards the return of Omontys and a buyout of Affymax by Takeda!!!
Reintroduction or not is binary. Outcomes beyond that, such as acceptance and sales are anything but. Therefore outcome for AFFY is not binary. Lack of reintroduction however has a singular outcome.
Not quite right, but is dependent on Fresenius staying on board. They control 40% of the market, are under immense pressure to get their costs down and I KNOW for a fact that they have it in for Amgen!!! Sorry, can't tell you about that other than you'll have to take that one on faith or not?
Ok, I don't think people should depend on you too much, people need to do their own homework and make the decisions, but also knowing that maxdad still on board does make the stress level go down.
Verification this is THE MAN! Anyone who doesn't think this is serious money making business should re-evaluate why you are here. Keep your eye on Q, if necessary write down the facts and re-read them often, listen to what Q is saying directly (think Pharmaman), verify maxdad007prime's analysis, record, and going forward predictions (it isn't that hard to do). ~$100 by years end, ~$150 for 2014. Simple math bears these number to be more than attainable. Also, you haven't lost a dime unless you sell, but you do have the potential to make an incredible amount. Jim
Sentiment: Strong Buy
Okay, I was on the wrong board; thought I was on QCOR. Same basic principles apply to AFFY, specifics apply to Q. Trying to post prior to getting out the door for Dr. appt. My apologies. Later, Jim